3Hammer RE,Maika SD,Richardson JA,et al.Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta Zm:an animal model of HLA-B27-associated human disorders.Cell,1990,63:1099-1112.
4Martinez-Borra J,Gonzalez S,Lopez-Vazquze A,et al.HLA-B27 alone rather than B27-related class Ⅰ haplotypes contributes to ankylosing spondylitis susceptibility.Hum Immunol,2000,61:131-139.
5Allen RL,Bowness P,McMicheal AJ.The role of HLA-B27 in spondyloarthritis.Immunogenetics,1999,50:220-227.
6Khare SD,Lee S,Bull MJ,et al.Peptide binding α2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice.Hum Immunol,1999,60:116-126.
7Garcia-Peydro M,Marti M,Lopez de Castro JA,et al.High T cell epitope sharing between two HLA-B27 subtypes (B2705 and B2709) differentially associated to ankylosing spondylitis.J Immunol,1999,163:2299-2305.
8Madden DR,Gorga JC,Stromingen JL,et al.The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.Cell,1992,70:1035-1048.
9Galocha B,Lamas JR,Villadangos JA,et al.Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B2704 and B2706 subtypes,and to mutants mimicking their polymorphism.Tissue Antigens,1996,48:509-518.
10Rudwaleit M,Bowness P,Wordsworth P.The nucleotide sequence of HLA-B2704 reveals a new amino acid substitution in exon 4 which is also present in HLA-B2706.Immunogenetics,1996,43:160-162.
